CatalystPit

BLTEBELITE BIO, INC

NASDAQ · Pharmaceutical Preparations
Last close $169.82 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
RECENT INSIDER TRADES
  • 2026-10-05 · Scholl Hendrik Peter (Chief Medical Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders81
Shares held9,374,362
Value$1.41B
Percent of shares outstanding23.83%
As of quarter end2026-06-30
RECENT NEWS
  • Belite Bio CMO Scholl sells $82,658 in shares
  • Belite Bio to present data at Innovate Retina and AAO conferences
  • Belite Bio to present data at Euretina conferences in Vienna
  • Belite Bio's tinlarebant nears FDA review
  • Belite Bio, Inc (BLTE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
BELITE BIO, INC (BLTE) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit